EBS Emergent Biosolutions Inc

Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.

$33.33  -3.34 (-9.11%)
As of 05/24/2022 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  11/15/2006
Outstanding shares:  50,243,624
Average volume:  1,043,463
Market cap:   $1,775,107,236
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B1HJLW5
Valuation   (See tab for details)
PE ratio:   11.70
PB ratio:   1.17
PS ratio:   1.01
Return on equity:   10.00%
Net income %:   8.96%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy